Enteric fever, encompassing both typhoid and paratyphoid fever, remains a significant health concern worldwide, particularly in developing countries. Rapid diagnosis and appropriate management are critical to reduce morbidity and mortality associated with this disease.
Traditional diagnostic methods, such as blood culture and Widal test, have limitations in terms of sensitivity, specificity, and turnaround time. Recent advancements have led to the development of molecular diagnostic tests like Polymerase Chain Reaction (PCR) and Nucleic Acid Amplification Tests (NAATs), which offer improved sensitivity and specificity, and faster results.
Increasing antimicrobial resistance, particularly to fluoroquinolones and third-generation cephalosporins, has complicated the management of enteric fever. This necessitates the use of culture and sensitivity tests to guide antibiotic therapy. Empiric treatment should now consider the local resistance patterns.
Vaccination plays a pivotal role in the management of enteric fever. The World Health Organization recommends the use of Ty21a and Vi polysaccharide vaccines in endemic areas. The newer conjugate vaccines, which have a longer duration of protection and can be given to younger children, are promising additions to the prevention strategy.
Supportive care, including hydration and antipyretics, remains a mainstay of treatment. In severe or complicated cases, hospitalization may be required. Post-treatment follow-up is crucial to ensure complete resolution of the disease and to monitor for potential complications.
An updated approach to the diagnosis and management of enteric fever includes the use of advanced diagnostic techniques, consideration of local antimicrobial resistance patterns, vaccination, and comprehensive patient care. As the disease landscape changes, it is essential for clinicians to stay informed about the latest developments to provide the best care for their patients.
1.
Toward rapid and comprehensive genetic diagnosis of pediatric cancer through adaptive sequencing
2.
Q&A: Why adolescents and young adults with cancer are falling behind
3.
Fixed-Duration Combo Shows Promise for Relapsed MCL
4.
Hospital receives 300 backpacks designed to help kids get leukemia treatment on the go
5.
A study has developed molecular markers that predict meningioma recurrence.
1.
Ultimate Guide to Oncology Services in the USA
2.
Exploring the Benefits of Teclistamab for Treating Advanced Cancer
3.
Glofitamab: A Breakthrough Therapy for Relapsed/Refractory Mantle Cell Lymphoma
4.
The Importance of Iron Rich Foods in Preventing and Treating Anemia
5.
Unexplained Weight Loss: Revealing Occult Cancers and Paraneoplastic Syndromes
1.
International Cancer Conference
2.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
3.
International Cancer Conference
4.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Updates on the First Line Management of ALK+ NSCLC
2.
Dacomitinib Case Presentation: Baseline Treatment and Current Status
3.
Recent Data Analysis for First-Line Treatment of ALK+ NSCLC: A Continuation
4.
Optimizing Treatment Options in Advanced Urothelial Carcinoma
5.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part II
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation